Discover how Your Pill's new allergy medical service helps patients manage hay fever symptoms effectively through online consultations.

Inimmune Corporation has announced key appointments in its leadership team, including a new Chief Medical Officer and Head of Financial Strategy, aligning their growth strategies for upcoming clinical milestones.

Hoth Therapeutics has received a Notice of Allowance for a groundbreaking patent on a new therapy aimed at treating allergic diseases. This advanced method offers a fresh approach to immunomodulation.

From February 2, 2026, Fit Clinic will offer pollen allergy treatments through both in-person and online consultations, ensuring prompt delivery of medications.

A groundbreaking lipid nanoparticle vaccine shows promise in managing severe allergies, offering new hope against the global allergy epidemic.

Latitude Food Allergy Care partners with Children's Hospital Los Angeles to provide essential food allergy treatments across Southern California, opening four new clinics.

At the upcoming 2025 AAAAI Annual Meeting, Nasus Pharma will reveal significant insights from clinical trials of FMXIN002, a groundbreaking intranasal epinephrine product.

Keymed Biosciences announces the approval of Stapokibart by China's NMPA for treating seasonal allergic rhinitis, showcasing significant clinical benefits.